Recombinant human prourokinase (Shanghai Shiyekehua Biotech)
重组人尿激酶原（上海实业科华生物药业）
Report date: 2022/01/22 15:45:57
Base Information
Drug NameRecombinant human prourokinase (Shanghai Shiyekehua Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Kehua Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesShanghai Kehua Biopharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A